Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 μg and 400/10 μg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids-Reference-Cited by-同舟云学术

Twelve-week efficacy and safety study of mometasone furoate/formoterol 200/10 μg and 400/10 μg combination treatments in patients with persistent asthma previously receiving high-dose inhaled corticosteroids

Published:2010-07-01 Issue:4 Volume:31 Page:280-289
ISSN:1088-5412
Container-title:Allergy and Asthma Proceedings
language:en
Short-container-title:allergy asthma proc

Author:

Weinstein Steven F.,Corren Jonathan,Murphy Kevin,Nolte Hendrik,White Martha,

Publisher

Oceanside Publications Inc.

Subject

Pulmonary and Respiratory Medicine,General Medicine,Immunology and Allergy

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Asthma management with triple ICS/LABA/LAMA combination to reduce the risk of exacerbation: an umbrella review compliant with the PRIOR statement;Expert Opinion on Pharmacotherapy;2024-05-23

2. Addition of long-acting beta2 agonists or long-acting muscarinic antagonists versus doubling the dose of inhaled corticosteroids (ICS) in adolescents and adults with uncontrolled asthma with medium dose ICS: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2023-08-21

3. Effectiveness and tolerability of dual and triple combination inhaler therapies compared with each other and varying doses of inhaled corticosteroids in adolescents and adults with asthma: a systematic review and network meta-analysis;Cochrane Database of Systematic Reviews;2022-12-06

4. Impact of inhaled fluticasone propionate/salmeterol on health-related quality of life in asthma: A network meta-analysis;Respiratory Medicine;2022-11

5. Pharmacogenetic Aspects of Type 2 Diabetes Treatment;Acta Biomedica Scientifica (East Siberian Biomedical Journal);2020-07-13